CuraScientific Corp.
CSTF
$0.00
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 952.82% | 426.73% | -90.17% | -60.02% | -15.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 952.82% | 426.73% | -90.17% | -60.02% | -15.83% |
| Cost of Revenue | 90.93% | 50.53% | 13.71% | 36.06% | 466.35% |
| Gross Profit | -36.21% | -13.11% | -25.08% | -47.98% | -789.29% |
| SG&A Expenses | 21.11% | 49.41% | -66.78% | -57.69% | 252.09% |
| Depreciation & Amortization | 18.00% | 26.67% | 25.76% | 30.40% | -26.83% |
| Other Operating Expenses | 0.00% | -50.00% | -50.00% | -200.00% | -166.67% |
| Total Operating Expenses | 58.30% | 49.67% | -58.77% | -50.35% | 67.90% |
| Operating Income | -32.31% | -33.64% | 58.19% | 50.18% | -72.92% |
| Income Before Tax | 835.48% | 720.35% | 91.70% | 10.25% | -10.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 835.48% | 720.35% | 91.70% | 10.25% | -10.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 835.48% | 720.35% | 91.70% | 10.25% | -10.22% |
| EBIT | -32.31% | -33.64% | 58.19% | 50.18% | -72.92% |
| EBITDA | -3.60% | -39.27% | 66.41% | 57.66% | -139.92% |
| EPS Basic | 102.64% | 101.62% | 99.84% | 90.68% | 76.21% |
| Normalized Basic EPS | 109.87% | 99.92% | 99.57% | 86.33% | 47.66% |
| EPS Diluted | 100.06% | 100.47% | 99.84% | 90.68% | 76.21% |
| Normalized Diluted EPS | 106.25% | 98.20% | 99.57% | 86.33% | 47.66% |
| Average Basic Shares Outstanding | 6,739.30% | 1,763.38% | 726.04% | 1,454.11% | 1,879.97% |
| Average Diluted Shares Outstanding | 7,024.01% | 2,303.38% | 726.04% | 1,454.11% | 1,879.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
